» Articles » PMID: 19932200

Multiple Sclerosis: Geoepidemiology, Genetics and the Environment

Overview
Journal Autoimmun Rev
Publisher Elsevier
Date 2009 Nov 26
PMID 19932200
Citations 201
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been extensively studied. We review the geographic epidemiology of the disease, the influence of immigration, age at immigration, clustering and epidemics. Various presumptive risk factors are discussed such as ultraviolet radiation, vitamin D, Epstein-Barr virus and infectious mononucleosis, other infectious agents and non-infectious factors. Two different hypotheses, the hygiene hypothesis and the prevalence hypothesis, were proposed to explain these environmental risk factors for MS. The epidemiological data, combined with pathological and immunological data, may contribute to the debate whether MS is an autoimmune disease, a latent or persistent viral disease, or a neurodegenerative disease.

Citing Articles

Enhancing classification of active and non-active lesions in multiple sclerosis: machine learning models and feature selection techniques.

Rostami A, Robatjazi M, Dareyni A, Ghorbani A, Ganji O, Siyami M BMC Med Imaging. 2024; 24(1):345.

PMID: 39707207 PMC: 11660597. DOI: 10.1186/s12880-024-01528-6.


Cognitive function and brain magnetic resonance imaging profiles in neuromyelitis optica spectrum disorder and multiple sclerosis.

Ashtari F, Najarzadeh P, Shaygannejad V, Adibi I, Ramezani N, Davanian F J Res Med Sci. 2024; 29:49.

PMID: 39403229 PMC: 11472874. DOI: 10.4103/jrms.jrms_703_23.


The role of the gut microbiota in neurodegenerative diseases targeting metabolism.

Fu Y, Gu Z, Cao H, Zuo C, Huang Y, Song Y Front Neurosci. 2024; 18:1432659.

PMID: 39391755 PMC: 11464490. DOI: 10.3389/fnins.2024.1432659.


Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA).

Chisari C, Amato M, Di Sapio A, Foschi M, Iaffaldano P, Inglese M J Neurol. 2024; 271(10):6801-6810.

PMID: 39190108 PMC: 11446943. DOI: 10.1007/s00415-024-12621-9.


NMR-based metabolomics identification of potential serum biomarkers of disease progression in patients with multiple sclerosis.

Alwahsh M, Nimer R, Dahabiyeh L, Hamadneh L, Hasan A, Alejel R Sci Rep. 2024; 14(1):14806.

PMID: 38926483 PMC: 11208524. DOI: 10.1038/s41598-024-64490-x.